Angiotensin II receptor blocker valsartan enhances glucose-induced insulin secretion
A number of antihypertensive drugs are known to be diabetogenic. This may contribute to less than expected decrease in the incidence of coronary heart disease with reduction in blood pressure with treatment in hypertensive patients. This study was aimed to determine the effects of a member, Valsarta...
Main Authors: | Ayob, Azizi, Hashim, Suhaimi, Azdan, Zulnizam, Abdul Razak, Tariq |
---|---|
Format: | Article |
Language: | English |
Published: |
Islamic World Academy of Sciences
2006
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/399/ http://irep.iium.edu.my/399/ http://irep.iium.edu.my/399/1/Medical_Journal_of_Islamic_World_Academy_of_Sciences.pdf |
Similar Items
-
Developing and validating a new comprehensive glucose-insulin pharmacokinetics and pharmacodynamics model
by: Ummu Kulthum, Jamaludin
Published: (2013) -
Kesan in vitro rilmenidine ke atas rembesan insulin
by: Hashim, Rosnani, et al.
Published: (2003) -
Receptor mechanisms of Thymoquinone-induced hypotension in normotensive rats
by: Mizher, Hussam A., et al.
Published: (2014) -
Low-dose methamphetamine addiction induced opioid receptor sensitization in polydrug-dependent mice
by: Ridzwan, Irna Elina, et al.
Published: (2018) -
Feasibility Of An Intensive Control Insulin-Nutrition Glucose Model ‘Icing’ With Malaysian Critically-Ill Patient
by: Normy Norfiza, A. Razak, et al.
Published: (2016)